| The Foundation was established with the vision that focused ultrasound would improve the quality of life and decrease the cost of care for millions of patients.
2016 was our most successful year, and as a result we see this vision coming closer to reality. The dialogue has shifted from if focused ultrasound can become a mainstream standard of care to when it will.
The number and diversity of mechanisms by which focused ultrasound affects tissue are expanding, creating the possibility to treat an even wider variety of medical disorders. Indications currently in research, development, and commercialization have skyrocketed to more than 75 from just a handful a decade ago. The number of research sites, investigators, regulatory approvals, commercial treatment sites, and patients treated all show impressive growth.
The 2017 State of the Field Report includes new charts, graphs, and timelines not in previous versions. These additions present a longitudinal view of how the field has grown over time, further demonstrating its impressive trajectory.
Read this report to find out more about the:
- Increasing number of research sites and regulatory approvals
- Dramatic upswing in first-in-human treatments
- Two indications dominating patient treatments worldwide
- Booming regulatory landscape